We are live on ! Find out more
EPIX

ESSA Pharma
EPIX

Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

10 hedge funds and large institutions have $1.49M invested in ESSA Pharma in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 1.18% → 1.19% (+0.01%)

0% more funds holding

Funds holding: 10 → 10 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

21% less capital invested

Capital invested by funds: $1.9M → $1.49M (-$404K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17.9K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$8.15K
3
UBS Group
UBS Group
Switzerland
+$2.15K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$8K
2
Citadel Advisors
Citadel Advisors
Florida
-$5.68K
3
Morgan Stanley
Morgan Stanley
New York
-$2.6K
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$68

EPIX Hedge Fund Activity: Q4 2017 in Review

10 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q4 2017, worth a combined $1.49M — down 21% from $1.9M a quarter earlier.

Fund positioning in EPIX was balanced in Q4 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $17.9K. The largest seller was Virtu Financial, exiting entirely with an estimated $8K sold.

  • 10 institutional investors held ESSA Pharma (EPIX) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1.49M of ESSA Pharma stock for Q4 2017, down 21% quarter-over-quarter.
  • 2 funds opened new ESSA Pharma positions in Q4 2017 and 2 closed out, a net change of 0 holders.
  • The largest ESSA Pharma buyer in Q4 2017 was Susquehanna International Group, an estimated $17.9K added.
  • The largest ESSA Pharma seller in Q4 2017 was Virtu Financial, an estimated $8K sold.

Based on aggregated 13F filings for Q4 2017.